Kynam Capital Management, LP Syndax Pharmaceuticals Inc Transaction History

Kynam Capital Management, LP

$1.18 Billion
Q3 2025

A detailed history of Kynam Capital Management, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Kynam Capital Management, LP holds 8,520,000 shares of SNDX stock, worth $142 Million. This represents 11.08% of its overall portfolio holdings.

Number of Shares

8,520,000

Previous 8,520,000 -0.0%

Holding current value

$142 Million

Previous $79.8 Million 64.25%

% of portfolio

11.08%

Previous 9.53%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$12.52 - $21.81 $33.5 Million - $58.4 Million	2,677,075 Added 45.82%	8,520,000 $113 Million
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $2.17 Million - $3 Million	120,868 Added 2.11%	5,842,925 $112 Million
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $1.17 Million - $1.48 Million	62,057 Added 1.1%	5,722,057 $117 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $23.5 Million - $44.6 Million	2,060,000 Added 57.22%	5,660,000 $122 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $4.91 Million - $7.36 Million	337,996 Added 10.36%	3,600,000 $52.3 Million

Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $1.08 Million - $1.25 Million	56,018 Added 1.75%	3,262,004 $68.3 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $13.3 Million - $18.7 Million	644,799 Added 25.18%	3,205,986 $67.7 Million
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $5.95 Million - $7.56 Million	288,272 Added 12.68%	2,561,187 $65.2 Million
Q3 2022 Nov 14, 2022	SELL	$18.51 - $24.79 $4.43 Million - $5.93 Million	-239,325 Reduced 9.53%	2,272,915 $54.6 Million
Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $7.9 Million - $11.3 Million	579,440 Added 29.98%	2,512,240 $48.3 Million
Q1 2022 May 13, 2022	BUY	$14.84 - $22.15 $14.5 Million - $21.6 Million	976,635 Added 102.14%	1,932,800 $33.6 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $14.6 Million - $21.5 Million	956,165 New	956,165 $20.9 Million

Others Institutions Holding SNDX

# of Institutions

253

Shares Held

99.8M

Call Options Held

1.41M

Put Options Held

737K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $940M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Account

Kynam Capital Management, LP Syndax Pharmaceuticals Inc Transaction History